High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Anne M. R. Schrader, Patty M. Jansen, Rein Willemze, Maarten H. Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F. Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie Jose Kersten, Michiel van den Brand, Wendy B. C. Stevens, Daphne de Jong, Myrurgia Abdul Hamid, Bea C. Tanis, Eduardus F. M. Posthuma, Marcel Nijland, Arjan Diepstra, Steven T. Pals, Arjen H. G. ClevenJoost S. P. Vermaat

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)2086-2089
Number of pages4
JournalBlood
Volume131
Issue number18
DOIs
Publication statusPublished - 3 May 2018

Keywords

  • CLINICAL PRESENTATION
  • TRANSLOCATION
  • CHEMOTHERAPY
  • FREQUENCY
  • RITUXIMAB
  • IBRUTINIB
  • ORIGIN
  • DNA

Cite this

Schrader, A. M. R., Jansen, P. M., Willemze, R., Vermeer, M. H., Cleton-Jansen, A-M., Somers, S. F., Veelken, H., van Eijk, R., Kraan, W., Kersten, M. J., van den Brand, M., Stevens, W. B. C., de Jong, D., Hamid, M. A., Tanis, B. C., Posthuma, E. F. M., Nijland, M., Diepstra, A., Pals, S. T., ... Vermaat, J. S. P. (2018). High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood, 131(18), 2086-2089. https://doi.org/10.1182/blood-2017-12-822817